Melanotan for Tanning: Gary Brecka's Claim vs the Safety Evidence
By Matt Cullerton, founder of Mavric and Apso
Melanotan is an injectable synthetic peptide that stimulates the skin's pigment cells to produce a tan. On The Megyn Kelly Show, Gary Brecka pitched it as a natural, healthier option than self-tanner. It does darken skin, but it is not approved by the FDA for any use, it is sold through unregulated channels, and published case reports link it to melanoma and changing moles.
What did Gary Brecka say about melanotan?
In a TikTok from @megynkellyshow, Megyn Kelly says her producer keeps warning her away from self-tanner. Brecka, a human biologist and podcaster, answers that there is "a peptide called melanotannin" that will tan skin "naturally." He says it "will activate melanocytes in your skin systemically" for "an even tan," and that sun exposure while using it will "accelerate your tan" so she gets "the darkest you you've ever" been.
He tells Kelly to "look it up," says "people are taking this and it's making them tan," and adds that it "has a bunch of other positive effects in the body." He calls it "sci-fi," offers a follow-up show in 45 days to show results, and tells Kelly she will "look Italian." The clip carries no captions, citations or safety disclaimers.
What is melanotan?
"Melanotannin" is a mispronunciation. The substance is melanotan, a synthetic analog of a hormone that stimulates melanin production. Two versions exist, melanotan I and melanotan II. Both are sold outside pharmacies, usually online as research chemicals or injectables.
Does melanotan work for tanning?
In a narrow sense, yes. Melanotan stimulates melanocytes and increases skin pigmentation, which is why people use it.
The claim of "a bunch of other positive effects in the body" is not supported by controlled human trials. The documented effects are mostly side effects:
- Nausea
- Facial flushing
- Prolonged erections
- Yawning
- Darkening of existing moles
Is melanotan FDA approved?
No. Melanotan has never been approved by the FDA for any use, and the FDA treats it as an unapproved new drug. The FDA has placed melanotan II in Category 2 of its 503A bulk drug substances review, the tier for substances that may present significant safety risks.
Because it is sold through unregulated channels, the purity, dose and contents of any given vial are unverified.
Can melanotan cause melanoma?
This is the risk the clip never raises. Because melanotan drives melanocyte activity, dermatologists worry it can change moles in ways that hide or promote skin cancer.
Published case reports describe:
- Patients who developed melanoma or melanoma in situ during or shortly after melanotan use
- Eruptive dysplastic nevi, new or rapidly changing moles that can be precursors to melanoma
- Pigmentation changes in the mouth after melanotan II injections, in a 2026 case report
Case reports do not prove that melanotan causes melanoma, and the number of documented cases is small. They do document real harms, which matter to anyone comparing an injection with a bottle of self-tanner.
Melanotan vs self-tanner: which is safer?
The Skin Cancer Foundation warns against injectable and intranasal tanning drugs and lists melanoma and systemic toxicity among the risks. It recommends topical sunless tanners instead.
Brecka's framing reverses that advice. He presents the unapproved injectable as the healthier choice and self-tanner as the thing to avoid. He also encourages sun exposure while on the drug to speed up tanning, which adds UV exposure on top of the pigment stimulation.
Bottom line
Melanotan will darken skin, but it is an unapproved injectable with no controlled evidence for wider health benefits and a small body of case reports linking it to melanoma and abnormal moles. Dermatology groups recommend topical self-tanner over any injectable tanning drug. Anyone already using melanotan should have new or changing moles checked by a dermatologist.
Sources
- The Skin Cancer Foundation warning on melanotan II - risks of injectable tanning drugs
- FDA: bulk drug substances that may present significant safety risks - the Category 2 list that includes melanotan II
- Eruptive melanocytic naevi following melanotan injection (PubMed) - case report of new and changing moles
- Changes in Oral Mucosa Associated with Melanotan II Injections (PMC) - 2026 case report on oral pigmentation
Published July 17, 2026. Based on a TikTok by @megynkellyshow. Full video notes (markdown)